7d6691c4116cff8d9904b64c3c1193f6cf877c6ee167cd5abf7ed1bdb5032c20

- Reimbursable Out-of-Pocket Expenses

Intercompany Eliminations

Other

Total Revenue

b3d762fc4ae521af3223973fac134031c27831641b67dfa8c14293b373a46995

Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

5fdbb0cc32bb0aa644f32273773532d0b03caffead4c108034dd735d0e7e1a5c

b1261abe56e7c2b5d37d58a54feda4071d3644f47991b5d41b150247484a156a

North America

- United States

- Canada

Europe

- United Kingdom

- Switzerland

- Other Europe

Other Regions

00739c46664c3880dfc0a3e06b7a2bacac6fde89f9d02b0ede1c57ebfa0153dc

Company organic revenue (percentage)

Company organic Base Business (percentage)

Company COVID-19 Testing (percentage)

Dx organic revenue (percentage)

Dx base business (percentage)

Dx COVID-19 Testing (percentage)

Dx total volume measured by requisitions (percentage)

Dx acquisition volume net of divestitures (percentage)

Dx organic volume (percentage)

Dx base business volume (percentage)

Dx COVID-19 Testing volume (percentage)

Dx price/mix (percentage)

Dx base business price/mix (percentage)

BLS organic growth (percentage)

Company base business (percentage)

85516ce3ae1280b9d65b186c241f1c7c3a8548c4441eda1ba1ef708c627079cc

9d265dceca87c6e4bb7d0f700945e2b41539fa1215ec2b52186232fabf8f1546

67284d5b780ee646ad60126822fedeeb6204ea6c6bece80de0690a9db4faadcb

Revenues (USD, millions)

Cost of revenues (USD, millions)

Gross profit (USD, millions)

Selling, general and administrative expenses (USD, millions)

Amortization of intangibles and other assets (USD, millions)

Goodwill and other asset impairments (USD, millions)

Restructuring and other charges (USD, millions)

Operating income (USD, millions)

Interest expense (USD, millions)

Investment income (USD, millions)

Equity method income (expense), net (USD, millions)

Other, net (USD, millions)

Earnings from continuing operations before income taxes (USD, millions)

Provision for income taxes (USD, millions)

Net earnings (USD, millions)

Less: Net earnings attributable to the noncontrolling interest (USD, millions)

Net earnings attributable to Laboratory Corporation of America Holdings (USD, millions)

Basic earnings per common share (USD)

Diluted earnings per common share (USD)

1491b6d522f20048033fa243322805d4f898d40d04d8b5551019c8aa74758d38

Labcorp Holdings Inc (LH)

Financials